University of Electronic Science and Technology of China
Chengdu, Sichuan, China
Location status: Recruiting
NCT Number: NCT07665216
The main aim of the present study is to investigate the effects of a Motivational Interviewing-based artificial intelligence chatbot on resting-state brain function in college students with elevated anhedonia and depressive symptoms. The study will use a randomized active-control intervention design with pre- and post-intervention resting-state functional magnetic resonance imaging assessments.
Interested in participating?
Request Info18 year–40 year
All sexes
Interventional
Not applicable
Chengdu, Sichuan, China
Location status: Recruiting
Anhedonia represents a core characteristic of depression and is characterized by reduced experience of pleasure. It is closely related to decreased motivation, altered reward processing, and alterations in intrinsic brain network function. Resting-state fMRI provides a way to examine intrinsic brain activity and functional connectivity without requiring participants to perform a specific task. This is important because changes associated with anhedonia may not only appear during reward-related tasks, but may also be reflected in spontaneous brain network organization.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The experimental chatbot is designed to use principles of Motivational Interviewing to support participants in exploring their personal values, motivation for change, and daily behavioral goals related to pleasure, engagement, and reward-seeking. During the intervention period, participants will interact with the chatbot regularly through brief text-based conversations. The chatbot will provide empathic, non-judgmental responses, encourage reflection on current difficulties, and help participants identify small, feasible actions that may increase daily engagement and positive experiences. It will not provide diagnosis, crisis counseling, or medical treatment.
Participants will interact with a chatbot matched in format and frequency of use. This chatbot will provide neutral nature-related stories or general natural history content. It will be designed to maintain participant engagement while avoiding therapeutic techniques, motivational interviewing strategies, behavioral activation guidance, or personalized mental health advice. This active control condition will help control for nonspecific effects of chatbot interaction, attention, expectancy, and digital engagement.
Time frame: Baseline before the first chatbot interaction and Week 1 after completion of the chatbot intervention.
Resting-state fMRI will be used to examine functional connectivity among predefined regions involved in reward, social, and self-referential processing. Connectivity will be estimated from Pearson correlations between regional BOLD time series and then converted using the Fisher z transformation. Changes from baseline to post-intervention will be reported as dimensionless Fisher z values.
Time frame: Baseline before the first chatbot interaction and Week 1 after completion of the chatbot intervention.
Indices of spontaneous neural activity in regions involved in motivation, social and self-referential processing, will be extracted from resting-state fMRI scans collected at the two assessment points. These indices will include amplitude of low-frequency fluctuations or fractional amplitude of low-frequency fluctuations, as well as regional homogeneity. Baseline and post-intervention values will then be compared to characterize pre-to-post changes.
Contact information is provided by the study sponsor or research team.
University of Electronic Science and Technology of China
Other
Effects of a Chatbot-Based Intervention on Resting-State Functional Connectivity and Spontaneous Neural Activity in Individuals With Anhedonia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07686393
Healthy
Bethesda, Maryland, United States
View Trial DetailsNCT07407348
Body Weight, Healthy
Nottingham, United Kingdom
View Trial DetailsNCT07169630
Alzheimer s Disease, Cognition Disorders
Bethesda, Maryland, United States
View Trial DetailsNCT01399385
Arterial Occlusive Diseases, Arteriosclerosis
Bethesda, Maryland, United States
View Trial Details